It inhibits S1PR1 expression after activation of S1PR1 on lymphocytes and limits the egress of lymphocytes from lymphoid tissues, thus reducing lymphocytic infiltration and reducing the extent of damage, and ameliorating local inflammation in the intestine in murine colitis (17, 18). The gene discussed is S1PR1; the disease is colitis.